● Recruiting

Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus

Condition: Keratoconus · Sponsor: Glaukos Corporation

PhasePhase 2

Planned participants100

Who can joinAll sexes, 18 Years to 55 Years

Healthy volunteersNo

About this study

Multi-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solution in subjects with keratoconus.

This description comes directly from the study's public registry record.

Talk to the study team

Study Manager · 949-739-8749 · ClinicalResearch@Glaukos.com

Always discuss trial participation with your own doctor first.

Locations (1)

Glaukos Clinical Study Site

Westerville, Ohio, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07400952